Abstract
General anesthetics are both neuroprotective and neurotoxic with unclear mechanisms. General anesthetics may control cell survival via their effects on autophagy by activation of type 1 inositol triphosphate receptor (InsP3R-1). DT40 or SH-SY5Y cells with only or over 99% expression of InsP3R-1 were treated with isoflurane or propofol. Cell viability was determined by MTT reduction or LDH release assays. Apoptosis was determined by measuring Caspase-3 or by TUNEL assay. Autophagy activity was determined by measuring LC3 II and P62. We evaluated mitochondrial integrity using MitoTracker Green and cytosolic ATP levels. Fura2-AM was used to measure the concentrations of cytosolic calcium ([Ca2+]c). Propofol significantly increased peak and integrated calcium response (P < 0.001) in cells with InsP3R-1 but not in cells with triple knockout of InsP3R. Both propofol and isoflurane increased autophagy induction (P < 0.05) in an mTOR- and InsP3R- activity dependent manner. Short exposure to propofol adequately activated InsP3-1 to provide sufficient autophagy for cytoprotection, while prolonged exposure to propofol induced cell apoptosis via impairment of autophagy flux through over activation of InsP3-1. Propofol damaged mitochondria and decreased cytosolic ATP. The effects of general anesthetics on apoptosis and autophagy are closely integrated; both are caused by differential activation of the type 1 InsP3R.
Similar content being viewed by others
Introduction
General anesthetics can be cardiac- or neuro-protective agents1,2. However, general anesthetics can also cause neuronal injury or death associated with behavioral and developmental abnormalities3. Intracellular Ca2+ homeostasis is important in maintaining cell survival and its disruption can result in cell damage4. Various GAs have demonstrated the ability to affect intracellular Ca2+ homeostasis via the InsP3 receptor (InsP3R) located on the membrane of the endoplasmic reticulum (ER). Among the three subtypes of InsP3R, the type-1 InsP3Rs (InsP3R-1) play important roles in many pathological conditions, including apoptosis, neuronal injury or death, ischemia and cell toxicity.
Autophagy is an adaptive survival response by cells to various stresses5. It is regulated by a number of protein kinases, with the mammalian target of rapamycin (mTOR) the best characterized6. Intracellular Ca2+ homeostasis, especially when regulated through activation of InsP3R, plays a crucial role in regulating autophagy. Ca2+ release from the ER via InsP3Rs elevates cytoplasmic Ca2+ concentration ([Ca2+]i) and activates autophagy via a mTOR-dependent pathway6. Considering InsP3R’s regulatory role in autophagy and the capacity of GAs to activate InsP3R7, it is reasonable to propose that GAs may control cell survival fate by affecting autophagy via differential activation of InsP3R.
Interestingly, newborn developing brains in various animal models and in some clinical studies have demonstrated a high sensitivity and vulnerability to anesthetic neurotoxicity8, with an unclear mechanism. One proposed mechanism is the disruption of intracellular Ca2+ homeostasis via excessive activation of InsP3R or ryanodine receptors (RYR)9. Notably, the expression of InsP3R may be associated with the maturation of neurons10. Apoptosis may also be significantly different between immature neurons and mature neurons because of differing autophagy regulation11. It is possible that differential effects of GAs on autophagy via activation of InsP3R may account for the high vulnerability of the developing brain to GA-mediated neuronal injury or death.
In various cell culture models, we have demonstrated that low concentrations of isoflurane or propofol for short durations stimulate cytoprotective autophagy by an mTOR-dependent pathway via adequate activation of InsP3R-1. However, GAs at high concentrations for prolonged use can impair autophagy flux and cause cell death via over-activation of InsP3R-1. Our study discloses a novel molecular mechanism for GAs’ dual effects of cytoprotection and cytotoxicity, which may provide a basis for better utilization of GAs.
Results
Anesthetic-induced autophagy via mTOR-dependent pathway by activation of type 1 InsP3R
Similar to inhalational GAs12,13,14, propofol significantly increased [Ca2+]c in wild type DT40 chicken lymphocytes but virtually not in DT40 cells with triple knock out of all isoforms of InsP3R (TKO), when measured during the peak elevation of [Ca2+]c in WT control cells (Fig. 1a,b, 58.6 ± 3.9 vs 7.4 ± 0.5, P < 0.0001). The average integrated Ca2+ responses calculated as the area under the curve (AUC) increase above its baseline after exposure to propofol, was significantly decreased in TKO cells compared to its WT control (Fig. 1c, 109999 ± 7752 vs 37540 ± 2771, P < 0.001). In SH-SY5Y cells which predominantly express (99%) of InsP3Rs-1, propofol alone significantly elevated [Ca2+]c, an effect that was significantly attenuated by the Ca2+ chelator, BAPTA-AM, at the time when [Ca2+]c reached its peak level in the absence of BAPTA-AM (Fig. 1e, 318 ± 58 vs 140 ± 63, P < 0.001) and the average AUC increase above its baseline after exposure to propofol (Fig. 1f, 154375 ± 11 vs 26148 ± 4, P < 0.0001).
Propofol induced Ca2+ release from the ER via activation of InsP3R. (a) Typical response of propofol (pfl)-mediated elevation of cytosolic Ca2+ concentration ([Ca2+]c), which was indirectly reflected by measuring the 340/380 ratio using the Ca2+ indicator dye Fura-2 AM in DT40 WT or TKO cells (a–c) or SH-SY5Y cells (d–f). Compared to DT40 chicken lymphocyte WT cells, TKO cells with triple knockout of InsP3R were resistant to pfl-mediated peak elevation in [Ca2+]c (a–c). TKO (a–c) or BATPA-AM at 10µM (d–f) dramatically attenuated pfl-mediated peak elevation of [Ca2+y]c (b and e), as well as the average integrated Ca2+ responses calculated as the area under the curve (AUC) (c and f), as an increase above its own baseline before addition of propofol at 200 µM. Statistical analysis was performed for cytosolic Ca2+ level at the time of peak elevation and AUC in DT40 (b and c) or in the presence or absence of BAPTA-AM in SH-SY5Y cells (e and f). All values represent Mean ± SEM from the average of at least 30 cells measured from a minimum of four separate experiments (N ≥ 4). **** means P < 0.0001 (b,e,f), *** means P < 0.001 (c).
Elevation of [Ca2+]c via activation of InsP3R has been shown to release Beclin-1 from BCL-215, which induces autophagy via a mTOR-dependent pathway by sequential activation of phosphorylated AMPK, inhibition of mTOR function and subsequent stimulation of autophagy6. As both isoflurane7 and propofol (Fig. 1) can activate InsP3Rs and raise [Ca2+]c, we examined if those commonly used GAs (isoflurane vs. propofol) affect autophagy in a mTOR-dependent pathway. In DT40 cells, propofol significantly increased levels of LC3II—a biomarker for autophagy activity and flux—in TKO cells with sole expression of type 1 InsP3R (InsP3R-1) but not in TKO DT40 cells (Fig. 2a, P < 0.05). We then compared changes in LC3II in both autophagosomes and autolysosomes by using a mRFP-GFP-LC3 construct and transfection procedure described previously16 in WT or TKO DT40 cells after treatment of 2.4% isoflurane for 24 h. Triple knockout of InsP3Rs (TKO) showed an increase in baseline autophagosomes (Fig. 2b, yellow puncta) and autolysosomes (Fig. 2c, red puncta), similar to previous reports on the mTOR-independent pathway model17 and the results in Fig. 2a. Isoflurane significantly increased LC3II in autophagosomes (Fig. 2b, P < 0.05) and autolysosomes (Fig. 2c, P < 0.01) in wild type cells, but the increase was not as dramatic (2b) or was absent (2c) in TKO cells. Similar to its effects on DT40 cells, propofol dose-dependently increased LC3II (Fig. 2d) in SH-SY5Y. This change was significantly promoted by the autophagy stimulator, rapamycin (Fig. 2e, P < 0.05), but was inhibited by the InsP3R antagonist, xestospongin C (Fig. 2f, 0.51 ± 0.05 vs 0.92 ± 0.06, P < 0.05), and siRNA of type 1 InsP3R (InsP3R-1) (Fig. 2e, P < 0.05). To examine if elevated [Ca2+]c (Fig. 1) is involved in propofol’s effects on autophagy, we used BAPTA-AM to blunt elevation of [Ca2+]c. BAPTA-AM significantly ameliorated elevation of LC3II induced by propofol (Fig. 2g, 0.31 ± 0.09 vs 1.6 ± 0.15, P < 0.001) in SH-SY5Y cells. Since the inhibition of mTOR regulates the induction of mTOR-dependent autophagy triggered by elevation of cytosolic Ca2+ 6, we further investigated the effects of GAs on mTOR activity. Propofol significantly inhibited mTOR, as evidenced by the decreased mTOR product p-S6K dose-dependently in SH-SY5Y cells (Fig. 2h, P < 0.01 or P < 0.001). This inhibition depended on the presence of InsP3R-1 because absence of InsP3R in TKO DT40 cells abolished propofol's ability to decrease p-S6K (Fig. 2i, P < 0.05).
Isoflurane and propofol stimulate autophagy in an InsP3R- and mTOR- dependent pathway. In DT40 chicken lymphocyte cells, autophagosome biomarker LC3II protein determined by Western Blot was significantly increased under the 200 µM propofol (Pfl) treatment for 2.5h in DT40 cells with expression of only type 1 InsP3R (R1), but not as much in DT40 with triple knock out of InsP3Rs (TKO) cells (a). (b,c) DT40 WT or TKO cells stably overexpressing the mRFP-GFP-LC3 constructs were treated with 2.4% isoflurane (Iso) for 24 h. Baseline autophagy activity (both autophagosome and autolysosome) increased in TKO compared to WT cells. 2.4% Iso for 24 h significantly increased condensed LC3-II in both autophagosomes (b) and autolysosomes (c) in WT but not in TKO cells. Data: Mean ± SEM, one-way ANOVA followed by Dunnett’s post hoc test. *P < 0.05, **P < 0.01, ++P < 0.01, #P < 0.05, ##P < 0.01 compared to wild type control (WT). In human SH-SY5Y neuroblastoma cells, propofol treatment for 2.5 hours at indicated concentrations dose-dependently increased the autophagosome biomarker LC3II (d), starting at a pharmacological concentration of 200 µM, and could be significantly augmented by a 30 minute pretreatment with the autophagy stimulator rapamycin at 1 µM (e), but inhibited by siRNA of type 1 InsP3R (InsP3R-1) (e), 30 min pretreatment of InsP3R inhibitor xestospongin C at 2 µM (f) and BAPTA-AM at 10 µM (g). Propofol dose- and InsP3R-1- dependently inhibited mTOR by demonstrating a proportional decrease of the mTOR enzyme product p-S6K in SH-SY5Y cells (h) and DT40 cells with expression of type 1 InsP3R but not in TKO cells (i). Data represent Mean ± SEM from a minimum of 2 repeats of 3 separate experiments (d–i, N ≥ 3), one-way ANOVA followed by Dunnett’s post hoc test. *P < 0.05, **P < 0.01, ***P < 0.001. #P < 0.05.
Adequate autophagy is protective against propofol-induced cytotoxicity
Because autophagy activity plays an essential role in determining cell survival fate18, we explored the effects of GAs on cell death via autophagy. Previous studies have suggested that adequate autophagy is cytoprotective against various types of detrimental stresses19. Although propofol caused dose-dependent cytotoxicity in SH-SY5Y cells, general inhibition of autophagy by 3-MA significantly increased this propofol cytotoxicity (Fig. 3a, P < 0.001). On the other hand, impairment of autophagy flux may be cytotoxic and promote cell death when induced by various stress20. Bafilomycin and chloroquine both further significantly increased propofol-induced neuronal injury or death in SH-SY5Y cells, possibly by impairing autophagy flux (Fig. 3b, P < 0.05, P < 0.001). We further demonstrated that adequate propofol exposure may stimulate autophagy via activation of InsP3R-1 and provide cytoprotection, as the autophagy inhibitor 3-MA could only potentiate propofol-induced cytotoxicity in DT40 TKO cells but not in TKO cells with expression of type 1 InsP3R (Fig. 3c, P < 0.05).
Adequate autophagy protects cells from propofol toxicity. (a) SH-SY5Y human neuroblastoma cells were treated with 200 µM propofol alone or together with 5mM autophagy general inhibitor 3-MA for 24h in medium without serum. (b) SH-SY5Y Cells were treated with 200µM propofol in the absence or presence of 40nM bafilomycin (Baf) or 10 µM chloroquine (Chloro) pretreatment for 30 min. Supernatants were collected for LDH release assay. (c) DT40 cells with triple knockout of InsP3R (TKO) or TKO with expression of recombined type 1 InsP3R (R1) were treated with either 200µM propofol alone or in combination with 10µl of autophagy inhibitor 3-MA for 24h. Cell viability was then measured with MTT assay. Cell damage was determined by LDH release assay in SH-SY5Y cells after treatment with propofol at various concentrations either with 30 min pretreatment of intracellular Ca2+ elevation inhibitor 5 µM BAPTA-AM (d) or in the culture medium without addition of Ca2+ to maximally inhibit Ca2+ influx (e). Data represent Mean ± SEM from at least four separate experiments (N ≥ 4), one-way ANOVA followed by Dunnett’s post hoc test. *P < 0.05, ***P < 0.001.
Taking this result one step further, we determined the role of [Ca2+]c elevation in propofol cytotoxicity. Buffering the elevation of [Ca2+]c by BAPTA-AM significantly potentiated propofol-induced cytotoxicity (Fig. 3d, P < 0.05), which could be attributed to deficient autophagy stimulation by adequately elevated [Ca2+]c (Fig. 1). Finally, to examine the role of Ca2+ influx from the extracellular space in propofol cytotoxicity, we used media depleted of Ca2+ during propofol treatment. Similar to BAPTA-AM, inhibition of Ca2+ influx potentiated propofol-induced toxicity, possibly by inhibiting the physiological autophagy stimulated by adequate elevation of [Ca2+]c (Fig. 3e, P < 0.05).
Excessive autophagy or impairment of autophagy flux promotes GA-mediated cytotoxicity.
When SH-SY5Y cells were differentiated into neurons, they were much more sensitive to propofol-induced cytotoxicity, as measured by MTT release assay, even at concentrations as low as 5 µM, a clinically relevant plasma concentration, compared to non-differentiated SH-SY5Y cells (Fig. 4a, 96.2 ± 1.3 vs 86.9 ± 2.4, P < 0.05). Additionally, propofol-induced cytotoxicity is not only dose-dependent (Fig. 4a) but also time-dependent (Fig. 4b), which is consistent with the toxic effects of other inhalational GAs 13. It seems that propofol-mediated autophagy and apoptosis are closely related to each other because the biomarkers for apoptosis (TUNEL) and for autophagy stimulation or flux impairment (elevation of LC3II) increased in parallel after propofol treatment of propofol in WT DT40 cells (Fig. 4c, 13.9 ± 1.0 vs 27 ± 2.2, P < 0.05 and 4d, 5.9 ± 0.6 vs 16.1 ± 1.1, P < 0.0001). Similarly, excessive stimulation of autophagy by rapamycin in SH-SY5Y differentiated neurons significantly potentiated propofol-induced cytotoxicity (Fig. 4e, P < 0.01 or 0.001) and apoptosis (Fig. 4f, P < 0.05). The propofol-mediated increase of LC3-II could represent either the stimulation of autophagy or impairment of autophagy flux, especially the conversion of autophagosomes to autolysosomes.
Anesthetic-induced cell death was associated with anesthetics’ regulatory effects on autophagy activity via activation of InsP3Rs. (a) In SH-SY5Y human neuroblastoma cells, propofol treatment at various concentrations for 24 h induced cell damage (MTT reduction) in a dose-dependent manner, with differentiated SH-SY5Y neurons displaying more sensitivity to propofol toxicity, even at clinically relevant concentrations (up to 20 µM). (b) In DT40 chicken lymphocytes with triple knock out of InsP3R (TKO) or TKO with expression of recombinant type 1 InsP3R (R1), treatment with 200 µM propofol time-dependently induced cell death, as represented by reduced MTT in R1 but not TKO cells. (c) Propofol at 50 µM for 2 h induced apoptosis in DT40 WT, showing significantly increased TUNEL positive cells and the parallel elevation of the autophagy activity biomarker LC3II (d) Scale bar=100µM (c and d). (e) Autophagy stimulator rapamycin at 1 µM significantly potentiated propofol-mediated reduction of MTT and elevation of active caspase-3 (f), which is representive of cell damage by apoptosis. (g) Bafilomycin (Baf), an inhibitor of the autolysosome formation stage of autophagy maturation, did not increase LC3II induced by propofol further, suggesting propofol-mediated impairment of autophagy flux from autophagosomes to autolysosomes. (h) DT40 TKO or R1 cells were treated with propofol at 100 (P100) or 200 (P200) µM for 24h before being collected for western with anti P-S6K. i) In SH-SY5Y human neuroblastoma cells, a short incubation of 200 µM propofol (2 h) trended to increase while prolonged 200 µM propofol exposure (24 h,j) trended to decrease P62 degradation measured by Western Blot, indicating dual effects of propofol for both increasing autophagy activity at short exposure and impairing autophagy flux from autophagosome to autolysosome at prolonged exposure. Data represents Means ± SEM from a minimum of 4 separate experiments (a–j). One-way (f,g,j) or two-way (a,d,e) ANOVA followed by Dunnett’s post hoc test or student t test (c,d,i,j) *P < 0.05; **P < 0.01, ***P < 0.001 compared to corresponding control respectively.
We further determined that propofol at high concentrations (200 µM, Fig. 4g) elevated LC3-II with concomitant use of bafilomycin, an inhibitor of lysosome function and autolysosome formation21 and an agent capable of differentiating the causes of LC3II elevation. Bafilomycin is a relatively selective agent that impairs autophagy flux by itself. If propofol increases LC3-II by stimulation of autophagy induction, addition of bafilomycin will increase LC3-II further more. Otherwise it will indicate that propofol impair autophagy flux. Propofol did not further increase LC3II even in the presence of bafilomycin (Fig. 4g, P < 0.01), suggesting that propofol at a high concentration (200µM) for a prolonged duration (24 h) increased LC3-II by impairment of autophagy flux rather than induction of autophagy activity, further worsening propofol-mediated apoptosis (Fig. 4c).
In contrast to its stimulatory effect on autophagy through inhibition of mTOR after short exposure (Fig. 2h and i, 2.5 hr), propofol at the same concentration (200 µM) for a prolonged exposure (24 h) inhibited autophagy induction by increasing activation of mTOR via activation of InsP3R, as evidenced by the increased mTOR product p70-56 k only in DT40-R1 but not in TKO cells (Fig. 4h, P < 0.05). These results suggest that excessive propofol exposure may have negative feedback activation on mTOR function and can inhibit autophagy induction via over-activation of InsP3R-1.
p62 is an ubiquitin- and LC3-binding protein that is degraded by the autophagy-lysosome pathway and is accumulated during deficient autophagy or during impaired autophagy flux22. Similar to its dual effects on mTOR activity (Figs 2h and i vs. 4h), propofol at 200 µM for 2 or 24 h affected the p62 level differentially, decreasing at short exposure but increasing at prolonged exposure (Fig. 4i 1.17 ± 0.15 vs 0.74 ± 0.19, P < 0.05 and 4j, 2.1 ± 0.21 vs 2.6 ± 0.13, P < 0.05). Therefore short exposure of propofol increased autophagy stimulation via a mTOR-dependent pathway (Fig. 2h and i) and promoted autophagy flux, providing cytoprotection (Fig. 3), while prolonged propofol exposure impaired autophagy flux (Fig. 4g and h) and thus decreased the turnover of p62 via the autophagy-lysosome pathway (Fig. 4j), inducing cytotoxicity.
Anesthetics impaired autophagy by disruption of mitochondria and lysosome function
As mitochondria and lysosome function are integral to autophagy23 and cell death24, we investigated if GA effects on mitochondria and lysosome function influence autophagy. In SH-SY5Y cells, propofol at prolonged treatment (24 h) obviously disrupted mitochondria structure in a single cell, as shown by mitochondria green staining (Fig. 5a). As for mitochondria function, propofol for prolonged (24 h) but not short (4 h) exposure significantly decreased ATP production, an indirect biomarker for impaired mitochondria function, in the cytosolic space (Fig. 5b, (100 ± 16.4 vs 46 ± 3.85, P < 0.05), consistent with the dual effects of propofol on cell damage (Fig. 3 vs. Figure 4) and autophagy (Fig. 4i,j). Excessive activation of InsP3R may deplete ER Ca2+ and therefore impair protein maturation inside the ER, like that of V-ATPase, a hydrogen pump that transports H+ from the cytosolic space into the lysosome lumen to maintain a low intraluminal pH25. We determined if excessive use of propofol impairs autophagy flux by disrupting lysosome function via increased pH inside the lysosome. Using lysosensor staining to monitor lysosome pH26, we demonstrated that propofol at prolonged exposure (24 h) but not short exposure (5 h) elevated lysosomal pH with robust reduced lysosensor signal (Fig. 5c). Eventually, the disruption of lysosome function will impair the turnover of autolysosomes and disrupt the normal function of autophagy. We can demonstrate this disruption by an increase of the lysosomal protein LAMP1, an important biomarker for autophagy flux from autophagysomes to autolysosomes27. Propofol at prolonged exposure significantly increased the LAMP1 protein level (Fig. 5d, 1.07 ± 0.08 vs 2.35 ± 0.23, P < 0.05), indicating decreased autolysosome turnover and impaired autophagy flux and providing a distinct mechanism for propofol-mediated elevation of LC3II in both tissue culture and animal studies (Fig. 4d,g,i,j,l).
Propofol caused mitochondrial damage and elevated lysosomal pH. In SH-SY5Y human neuroblastoma cells, 200µM propofol for 24h obviously damaged mitochondria structures. (a) Pictures represented typical and repeatable changes of mitochondria structure in a single SH-SY5Y cell. (b) Prolonged exposure with 200 µM propofol for 24h, but not 4h, significantly reduced cytosolic ATP levels. (c) SH-SY5Y cells were treated with 200µM propofol for 5 or 24h before being stained for lysosome pH. Picture represented a typical and repeatable increase of lysosome pH. Scale bar, 10µm. (d) Prolonged exposure with 200 µM propofol for 24 h significantly increased lysosome protein LAMP1 expression measured by Western Blot.
Proposed mechanism of dual effects of cytoprotection and cytotoxicity by GAs by their differential effects on autophagy via activation of InsP3R
Moderate elevation of [Ca2+]c by short exposure of general anesthetic via adequate activation of InsP3Rs may increase physiological autophagy activity via a mTOR-dependent pathway (Figs 2 and 6) and provide cytoprotection (Figs 3 and 6). Inhibition of this adequate autophagy by 3-MA or by impairing adequate elevation of [Ca2+]c may promote GA-caused cell death (Figs 3 and 6). On the other hand, prolonged use of general anesthetics at high concentrations may cause over activation of InsP3R and abnormal elevation of [Ca2+]c, which may result in mitochondrial overload of Ca2+, disruption of mitochondria structure, collapse of mitochondrial potential, and reduction of normal ATP production (Fig. 5). Over-activation of InsP3R and the subsequent abnormal Ca2+ release from the ER may impair lysosome function (Fig. 5) in the following two ways: 1). Increased pH inside the lysosome’s lumen; 2). Impairment of autophagosome and lysosome fusion, and autophagy flux, due to the abnormally high level of [Ca2+]c 28. All these effects individually or coordinately impair autophagy flux and promote cell death or neurodegeneration (Figs 4, 5 and 6).
Dual effects of general anesthetics on autophagy and associated apoptosis. Moderate elevation of [Ca2+]c by GA-mediated adequate activation of InsP3R receptors for a short duration may increase autophagy activity via a mTOR-dependent pathway and inhibit apoptosis (left side). Rapamycin increased while 3-MA decreased autophagy. On the other hand, abnormal elevation of [Ca2+]c by GA-mediated excessive activation of InsP3Rs for a prolonged duration may result in abnormal elevation of mitochondria Ca2+ concentration ([Ca2+]m) and impair autophagy flux by reducing ATP production and increasing lysosomal pH and subsequently impairing lysosome and autolysosome function, which ultimately promotes apoptosis. GA: General Anesthetics.
Discussion
Isoflurane alone at clinically relevant concentrations activates InsP3R and releases Ca2+ from the ER, increasing cytosolic and mitochondrial Ca2+ concentrations7,13,14. Indirect evidence suggests that sevoflurane and desflurane also activate InsP3R14. Intravenous anesthetic propofol, too, can activate InsP3R (Fig. 1). Likely, propofol activates the isoform InsP3R-1 because the neuroblastoma cells (SH-SY5Y) have primarily (>99%) InsP3R-1 (Fig. 1b)29. Considering InsP3R-1 is the primary subtype of InsP3R, an essential player in the regulation of cell survival, GAs may exert their effects on cell survival via activation of InsP3R-1 in neurons.
Anesthetics like halothane activate the other major ER Ca2+ release pathway, the RyR channel complex30, which is thought to be the basis for the dangerous clinical occurrence of malignant hyperthermia31. Like InsP3Rs, RyRs are expressed throughout the nervous system and play important roles in both normal cell function and in neurodegenerative disease32. Our previous study indicated the involvement of RyR activation in isoflurane-induced apoptosis in neuronal tissue cultures33. Thus, both InsP3R and RyR contribute to regulating intracellular Ca2+ homeostasis and may interact with each other through a common Ca2+-induced Ca2+ release pathway in normal neuronal function and neurodegeneration.
Although general anesthetics have been shown to be both neuroprotective and neurotoxic in both in vitro and in vivo models depending on the degrees of exposure9,34,35, the underlining mechanisms are unclear. The proposed mechanisms for anesthetic neuroprotection include: adequate preconditioning, generation of reactive oxygen species (ROS), activation of G-protein coupled receptors, moderate elevation of [Ca2+]c, etc. The proposed mechanisms for anesthetic neurotoxicity include: excessive and abnormal activation of NMDA and GABA A receptors, generation of free radicals, activation of P75 growth factors, inflammation and excessive elevation of [Ca2+]c, etc.36. Comparing these two processes, anesthetics often use similar mechanisms to be both neuroprotective and neurotoxic, with the degree of exposure and the level of activation on different pathways serving as the determining factor9,35. Like ischemic preconditioning37, adequate exposure of GAs may induce various endogenous neuroprotective pathways and provide neuroprotection, while excessive exposure to GAs may be overstep the limit of preconditioning and stress neurons enough to cause damage.
Regulation of intracellular Ca2+ homeostasis and its role in cell survival is quite complex. The rise of [Ca2+]c is required for both cytoprotection and cytotoxicity of GAs9. The difference between the two is the degree and duration of [Ca2+]c elevation. Concerning the degree of elevation, previous research suggested that a moderate elevation of [Ca2+]c (likely an increase from around 70 to 150 nM) is cytoprotective38 and an excessive elevation of cytosolic Ca2+ is cytotoxic, such as the glutamate excitotoxicity after cerebral ischemia (which is often multiple times above baseline)39. As for [Ca2+]c elevation duration, short exposure may be cytoprotective and prolonged exposure may be cytotoxic9. While the principle governing GAs’ dual effects on neuroprotection and neurotoxicity may be clear, the exact tipping point from neuroprotection at adequate GA exposure to neurotoxicity at excessive exposure may be varied among various types of cells, animal species and patients. Nevertheless, if this theory in preclinical studies is proven to be true in patients (partial support can already be found in some retrospective clinical studies where multiple rather than single anesthesia exposure was associated with learning or developing disorders40, it is critically important to delineate the safe GA doses and exposure durations in different patients for future guidelines of clinical practice. For now, it is reasonable to avoid excessive anesthesia exposure whenever possible, especially in patients vulnerable to anesthesia-mediated neuronal injury or death (e.g. the developing brains of children).
Activation of InsP3R may either inhibit autophagy via a mTOR-independent pathway17 or activate autophagy via a mTOR-dependent pathway6. Although a few previous studies41 have investigated or discussed GA effects on autophagy, the exact role of GA-mediated regulation of autophagy in cell survival or death and neurodegeneration in the developing brains was far from clear, especially the effects of GAs on intracellular Ca2+ homeostasis. In this pioneer study, we first demonstrated that GAs can either adequately stimulate autophagy and support cell survival or pathologically impair autophagy flux and cause neuronal injury or death via differential activation of type 1 InsP3R (Fig. 6), providing a novel mechanism for the detailed mechanisms of GA-mediated dual effects of neuroprotection and neurotoxicity. Current experiments have demonstrated that short or adequate exposure of propofol or isoflurane promote physiological autophagy and inhibit cell death via moderate activation of type 1 InsP3R and elevation of cytosolic Ca2+ concentration. So the adequate anesthetic exposure provide cytoprotection or neuroprotection. However, prolonged use of propofol or isoflurane may impair normal autophagy flux or function via and promote cell death via over activation of InsP3R and abnormal elevation of cytosolic Ca2+ concentration. Therefore, the current study provide a molecular mechanism explaining the dual effects of neuroprotection and neurotoxicity by propofol or isoflurane, which may be representive of intravenous or inhalational general anesthetics respectively.
Previous research has suggested that various GAs may have differing potencies to cause cell injury and death14,42. It seems that propofol is generally less potent in causing cytotoxicity than inhalational anesthetics43,44. From this study, we gather that propofol needs clinically non-relevant high concentrations and durations to cause cytotoxicity or changes in autophagy activity. In contrast, isoflurane can usually cause similar changes at clinically relevant concentrations and long durations. If confirmed in animal studies and in humans, propofol at clinically used concentrations and durations may be generally less potent than isoflurane in causing neuronal injury or death.
This study is clinically important, urging the construction of strategies to minimize the use of GAs so that they do not adversely impair autophagy function and result in brain or other organ damage. Based on the tissue culture data from this study and others, the toxicity to propofol usually starting at concentrations much higher than the clinical relevant concentrations. We assume that clinically used the propofol likely provides a plasma concentration that is cytoprotective rather than toxic, although this need to be confirmed in the future clinical studies. Isoflurane seems to be more toxic than propofol as it can cause cytotoxicity at concentrations within clinical relevant range, although frequently need long duration. Clearly, more clinical studies are urgently needed to compare relative possible unwanted neurotoxic effects between propofol and commonly used inhalational anesthetics and make sure safe concentrations of general anesthetics can be used to improve safety, especially in the developing brains which may be more vulnerable to general anesthetics mediated neurodegeneration.
Previous studies have demonstrated that propofol or isoflurane can be neuroprotective against brain damage after cerebral ischemia by promoting the physiological autophagy45,46,47, which is consistent to the results from this study. This in vitro study, together with other studies in tissue cultures48,49, provides molecular mechanism of neuroprotection by general anesthetics via promoting autophagy via adequate activation of InsP3 and ryanodine receptors. Isoflurane and propofol have also shown to be neurotoxic by themselves in the developing brains50,51,52 but the molecular mechanism through their effects on autophagy flux is not well studied. Current in vitro study suggest importance of dose and duration of general anesthetics on fate of either neuroprotection or neurotoxicity via regulation of autophagy, which need further extensive studies in both animals and patients.
This study has the following limitations: 1) Most of the propofol concentrations used are pharmacological rather than clinically relevant and less valuable to be used guiding clinical practice directly. Further studies in animals and humans are needed. 2) We have only determined the major points of the mTOR-dependent autophagy pathway induced by GAs but not the detailed points (Fig. 6), but this pioneering study will inspire more research work in the area of GA-mediated regulation of autophagy and its relationship with GA-induced cell death. 3) We primarily provide a correlative connection between GA-mediated regulation of autophagy and its effects on cell survival. More selective inhibition of autophagy such as siRNA or knock out of important autophagy regulators (e.g. mTOR, Beclin-1) may be needed, rather than just 3-HK or rapamycin, to confirm the role of autophagy in GA-mediated cell death in the future studies.
In summary, our results indicate that an adequate exposure level of isoflurane or propofol stimulates physiological autophagy via an mTOR-dependent pathway and provides cytoprotection. But, an excessive use of GAs impairs autophagy flux and function and promotes neuronal injury or death. A reasonable strategy to use GAs safely is to minimize their excessive use, at either extreme concentration or duration.
Materials and Methods
Reagents
DMEM/F-12, RPMI1640 culture media, BAPTA-AM, Fura2-AM and B27 were obtained from Life Technologies (New York city, NY, USA). MTT (3-(4, 5-dimethyithiazol-2-yl)-2,5-diphenyl-tetrazolium bromide), propofol, rapamycin, bafilomycin, retinoic acid, 3-MA, chloroquine and TMRE were purchased from Sigma (Saint Louis, MO, USA). 30% Acrylamide solution and nitrocellulose membrane (0.45µm) were obtained from Bio-Rad (Hercules, CA, USA). LC3B rabbit polyclonal Ab (#3868), beclin-1 rabbit mAb (#3495), AMPK rabbit mAb (#2603), p-AMPK rabbit mAb (#2535), p-S6K rabbit polyclonal Ab (#9205), LAMP1 (D2D11) XP Rabbit ab (#9091), and cleaved caspase-3 rabbit polyclonal ab (#9661) were obtained from Cell Signaling (Danvers, MA, USA) and used in 1:1000 dilution. p62 mouse monoclonal antibody (#28359,1:1000) was purchased from Santa Cruz (Dallas, TX, USA). GAPDH antibody (#9484, 1:1000) was acquired from Abcam (Cambridge, MA, USA).
Cell Culture
DT40 cells lacking the genes for all 3 isoforms of InsP3Rs (DT40-KO, RIKEN Cell Bank No. RCB 1467) and DT40-KO cells stably over-expressing the rat type 1 InsP3R (DT40-R1) were cultured as we described previously13. Cells were maintained in suspension culture in RPMI 1640 media containing 10% FCS, 1% chicken serum (CS), penicillin (100 units/ml), streptomycin (100 μg/ml), and glutamine (2 mM) at 37 °C in a 95% air and 5% CO2 humidified incubator. Initial suspension densities of DT40-KO and DT40-R3 were between 1 and 3 × 106 cells per ml and cells were passed every 2–3 days. SH-SY5Y were cultured in DMEM/F12 media with 10%FBS, 100 units/ml penicillin, and 100 units/ml streptomycin as previously described53. To differentiate neurons, 0.5ml SH-SY5Y cells were seeded from a confluent T75 into a 6-well plate, and 10µM retinoic acid (RA) and B27 were added into the medium, which was changed every two days. Under those conditions, neurons could be obtained after one week54.
Choice of General Anesthetics
Although isoflurane is not the most commonly used inhalational anesthetic, it is the most studied GA in the area of anesthetic-mediated neurotoxicity. Isoflurane may be more potent in causing cell damage compared to sevoflurane or desflurane14. Propofol is the most commonly used and most studied intravenous general anesthetic, with increasing clinical application in outpatient day surgery.
Immunofluorescence
Cells were rinsed briefly in PBS and fixed with 2–4% formaldehyde in PBS for 10 minutes at room temperature, and were permeabilized with 0.1% Triton X-100 in PBS for 5 minutes. Cells were then rinsed with PBS three times for 5 minutes each and blocked in 5% normal (goat) donkey serum in PBS for 60 minutes. The primary antibody was diluted 1:50 in PBS and was incubated overnight at 4 °C. The cells were rinsed in PBS for 5 minutes each with high salt PBS and then rinsed two more times for 2 min. They were then incubated in secondary antibody diluted with PBS for 1 to 2 hours at RT in the dark. Lastly, the coverslips were rinsed with PBS once and stained with Hoechst 33342 1:1000 in PBS for 2–5 minutes. After being washed with PBS 3X5 min, the cells were mounted with Gold antifade reagent, cured on a flat surface in the dark overnight and sealed with nail polish.
Cytotoxicity assays
The MTT reduction or LDH release assays determine relatively early or late stages of cell damage, respectively13. The LDH assay was performed using a Promaga kit CytoTox 96 Non-Radioactive Cytotoxicity Assay (Product number G1780) per manufacturer’s instructions. Cells were plated in a 24 well plate one day prior to the experiment. The first row was left blank and each treatment was done quadraplicately. After each treatment, 50 µl supernatant was collected from each well with equal amount of substrate. The collection was incubated for 30′ at room temperature in the dark and then read with a micro plate reader at 490 nm. For the MTT assay, cells were seeded in a 96 well plate. MTT was prepared using PBS to 5 mg/ml. After treatment, cells were changed into 100 µl fresh medium with 10 µl MTT per well and incubated for 4 h. The reactants were dissolved with 100 µl 10%SDS/0.01M HCl for 4 h or overnight. The results of both LDH release and MTT reduction assays were expressed as a percentage of control. TUNEL assay was performed per instructions of the manufacturer (Roche In Situ Cell Death Detection Kit, Fluorescein, product no 11684795910). Briefly fragmented DNA-3′-OH ends were labeled with fluorescein-dUTP in the presence of TdT enzyme. The coverslips were counterstained with DAPI.
Western blot analysis
The cells were seeded into a 6 well plate with 2ml of cells per well. Following treatment, cells were collected and spun down. They were washed with PBS and lysed in a buffer solution containing 50mM Tris/HCl, pH7.8, 150 mM NaCl, 1% Triton X-100, 100 uM PMSF, a 1X dilution of complete protease and a phosphotase inhibitor mixture (Roche) for 5 min and vortexed. The lysates were cleared by centrifugation at 12,000rpm for 10min. Protein samples were run on 8 or 15% polyacrylamide gels and transferred onto nitrocellulose membranes. Primary antibodies were incubated overnight at 4 °C. Each independent experiment was repeated three times. Protein amount was normalized with actin. The images were quantitated with ImageJ software (http://rsb.info.nih.gov/ij/).
Autophagy flux assay
To determine the autophagic flux (transition from autophagosome to autolysosome to lysosome), we used an mRFP-GFP-LC3 construct16. DT-40 were transfected with the mRFP-GFP-LC3 plasmid (Addgene, Cambridge, MA) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. One day after transfection, cells were exposed to 2.4% isoflurane for 24 hrs. Following isoflurane exposure, cultures were fixed and mounted on cover glasses for microscopy. Colocalized LC3 puncta in both autophagosomes (GFP+mRFP+, yellow color) and autolysosomes (GFP-mRFP+, red color) were quantified across all conditions indicated in texts or figures. Colocalization efficiency was measured with ImageJ software and all data are given as LC3-puncta per cell.
ATP level measurement
ATP level was measured per the instructions of ATPLite Luminescence ATP Detection Assay System (Perkin-Elmer) using the modified method described previously55. 50 μL of mammalian cell lysis solution was added to 100 μL of cell suspension per well of a microplate. The plate was shaken and then 50 μL substrate solution was added to the wells. The luminescence was measured with a BioTech Synergy H1 plate reader.
Mitochondria and lysosome staining
We used the methods described previously56. Cells were stained with 1µM MitoTracker Green (In Vitrogen) for 30′ and transferred to a phenol red free medium. TME staining was done by adding TMRE to cells in media to a final concentration of 50–400 nM and incubated for 20 minutes at 37 °C. Fluorescence was monitored and photographed using an Olympus IX70 inverted microscope and the IPLab version 3.7 Imaging Processing and Analysis software (Biovision Technologies, Exton, PA). Lysosomes were stained with 1µM LysoSensor Yellow/Blue DND-160 (Invitrogen) and imaged using a DAPI filter set.
Measurement of Cytosolic Calcium Concentration ([Ca2+]c)
[Ca2+]c was determined by measuring the F340/F380 ratio using Fura-2 fluorescence (Molecular probe, Eugene, OR) with a photometer coupled to an Olympus IX70 inverted microscope and the IPLab v3.7 Imaging Processing and Analysis software. The protocol to determine the F340/F380 ratio was similar to what we have described previously12,13,14 with some modifications. On the day of [Ca2+]c measurement, the cells were loaded with 2.5 µM Fura-2AM (Molecular Probes, Eugene, OR) in Krebs-Ringer buffer for 30 min at room temperature. The cells were then placed in a sealed chamber (Warner Instruments, Hamden, CT) connected with multiple inflow infusion tubes and one outflow tube, which provided constant flow to the chamber. The cells were washed with Krebs-Ringer buffer through one inflow tube for the baseline measurement and then exposed to propofol via a separate inflow infusion tube driven by a syringe pump (Braintree Scientific, Braintree, MA). The fluorescence signals of Fura-2/AM were measured with excitation at 340nM and 380nM alternatively and emission at 510 nM for a period up to 18 min for each treatment. The F340/F380 ratio, which correlated to the level of cytosolic Ca2+ concentration, was constantly determined after exposing cells to propofol. The results of the F340/F380 ratio were averaged from a minimum of 30 cells in at least three separate experiments. The peak cytosolic Ca2+ and integrated calcium response, represented by area under curve (AUC), were determined and compared.
Statistical Analysis
All data are expressed as the mean ± standard error of the mean (SEM). Statistical analysis was performed using Graphpad Prism 6. P < 0.05 was considered to indicate a statistically significant result. Each experiment was repeated at least three times. The experimental units (n) and statistical analyses used are indicated in the figures and legends.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Kitano, H., Kirsch, J. R., Hurn, P. D. & Murphy, S. J. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J. Cereb. Blood Flow Metab 27, 1108–1128 (2007).
Swyers, T., Redford, D. & Larson, D. F. Volatile anesthetic-induced preconditioning. Perfusion 29, 10–15 (2014).
Creeley, C. E. From Drug-Induced Developmental Neuroapoptosis to Pediatric Anesthetic Neurotoxicity-Where Are We Now? Brain sciences 6, https://doi.org/10.3390/brainsci6030032 (2016).
Clapham, D. E. Calcium signaling. Cell 131, 1047–1058 (2007).
Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27–42 (2008).
Hoyer-Hansen, M. et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol. Cell 25, 193–205 (2007).
Joseph, J. D. et al. General Anesthetic Isoflurane Modulates Inositol 1,4,5-Trisphosphate Receptor Calcium Channel Opening. Anesthesiology (2014).
Jevtovic-Todorovic, V. et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 23, 876–882 (2003).
Wei, H. & Inan, S. Dual effects of neuroprotection and neurotoxicity by general anesthetics: Role of intracellular calcium homeostasis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry (2013).
Parrington, J. et al. Expression of inositol 1, 4, 5-trisphosphate receptors in mouse oocytes and early embryos: the type I isoform is upregulated in oocytes and downregulated after fertilization. Dev. Biol. 203, 451–461 (1998).
Roux, C. et al. NMDA receptor blockade in the developing cortex induces autophagy-mediated death of immature cortical GABAergic interneurons: An ex vivo and in vivo study in Gad67-GFP mice. Exp. Neurol. 267, 177–193 (2015).
Zhao, Y. et al. Anesthetic-induced neurodegeneration mediated via inositol 1,4,5-trisphosphate receptors. J. Pharmacol. Exp. Ther. 333, 14–22 (2010).
Wei, H. F. et al. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors. Anesthesiology 108, 251–260 (2008).
Yang, H. et al. Inhalational anesthetics induce cell damage by disruption of intracellular calcium homeostasis with different potencies. Anesthesiology 109, 243–250 (2008).
Vicencio, J. M. et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death.Differ. 16, 1006–1017 (2009).
Kimura, S., Noda, T. & Yoshimori, T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452–460 (2007).
Cardenas, C. et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142, 270–283 (2010).
Puyal, J., Ginet, V., Grishchuk, Y., Truttmann, A. C. & Clarke, P. G. Neuronal autophagy as a mediator of life and death: contrasting roles in chronic neurodegenerative and acute neural disorders. Neuroscientist. 18, 224–236 (2012).
Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880–884 (2006).
Gozuacik, D. & Kimchi, A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23, 2891–2906 (2004).
Lopez-Sanjurjo, C. I., Tovey, S. C., Prole, D. L. & Taylor, C. W. Lysosomes shape Ins(1,4,5)P3-evoked Ca2+ signals by selectively sequestering Ca2+ released from the endoplasmic reticulum. J. Cell Sci. 126, 289–300, https://doi.org/10.1242/jcs.116103 (2013).
Komatsu, M. et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131, 1149–1163 (2007).
Cardoso, S. M. et al. Mitochondrial control of autophagic lysosomal pathway in Alzheimer’s disease. Exp. Neurol. 223, 294–298 (2010).
Smaili, S. S. et al. The role of calcium stores in apoptosis and autophagy. Curr.Mol.Med. 13, 252–265 (2013).
Lee, J. H. et al. Presenilin 1 Maintains Lysosomal Ca(2+) Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification. Cell Rep. 12, 1430–1444 (2015).
Lee, J. H. et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146–1158 (2010).
Mader, B. J. et al. Rotenone inhibits autophagic flux prior to inducing cell death. ACS Chem. Neurosci. 3, 1063–1072 (2012).
Sarkar, S. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. Biochem. Soc. Trans. 41, 1103–1130, https://doi.org/10.1042/BST20130134 (2013).
Wojcikiewicz, R. J. & Luo, S. G. Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase. Type I, II, and III receptors are differentially susceptible to phosphorylation and are phosphorylated in intact cells. J. Biol. Chem. 273, 5670–5677 (1998).
Akata, T., Nakashima, M. & Izumi, K. Comparison of volatile anesthetic actions on intracellular calcium stores of vascular smooth muscle: investigation in isolated systemic resistance arteries. Anesthesiology 94, 840–850 (2001).
Denborough, M. Malignant hyperthermia. Lancet 352, 1131–1136 (1998).
Paschen, W. & Frandsen, A. Endoplasmic reticulum dysfunction - a common denominator for cell injury in acute and degenerative diseases of the brain? J. Neurochem. 79, 719–725 (2001).
Wei, H. et al. Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res. 1037, 139–147 (2005).
Pan, C. et al. The potential dual effects of anesthetic isoflurane on hypoxia-induced caspase-3 activation and increases in beta-site amyloid precursor protein-cleaving enzyme levels. Anesth. Analg. 113, 145–152 (2011).
Peng, J. et al. Anesthetic preconditioning inhibits isoflurane-mediated apoptosis in the developing rat brain. Anesth. Analg. 119, 939–946 (2014).
Jevtovic-Todorovic, V., Boscolo, A., Sanchez, V. & Lunardi, N. Anesthesia-induced developmental neurodegeneration: the role of neuronal organelles. Front. Neurol. 3, 141, https://doi.org/10.3389/fneur.2012.00141 (2012).
Dirnagl, U., Simon, R. P. & Hallenbeck, J. M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26, 248–254, https://doi.org/10.1016/S0166-2236(03)00071-7 (2003).
Bickler, P. E., Zhan, X. & Fahlman, C. S. Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology. 103, 532–539 (2005).
Choi, D. W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett. 58, 293–297 (1985).
Wilder, R. T. et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 110, 796–804 (2009).
Perucho, J. et al. Trehalose protects from aggravation of amyloid pathology induced by isoflurane anesthesia in APP(swe) mutant mice. Curr.Alzheimer Res. 9, 334–343 (2012).
Liang, G. et al. Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice. Anesthesiology 112, 1325–1334 (2010).
Zhang, Y. et al. Anesthetic propofol attenuates the isoflurane-induced caspase-3 activation and Abeta oligomerization. PLoS One. 6, e27019 (2011).
Yang, B. et al. Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane. PloS One. 9, e99171 (2014).
Cui, D. R. et al. Propofol prevents cerebral ischemia-triggered autophagy activation and cell death in the rat hippocampus through the NF-kappaB/p53 signaling pathway. Neuroscience 246, 117–132 (2013).
Cui, D. et al. Propofol prevents autophagic cell death following oxygen and glucose deprivation in PC12 cells and cerebral ischemia-reperfusion injury in rats. PloS One. 7, e35324 (2012).
Li, G. & Yu, B. Elevation of protective autophagy as a potential way for preventing developmental neurotoxicity of general anesthetics. Med. Hypotheses 82, 177–180, doi:https://doi.org/10.1016/j.mehy.2013.11.032 (2014).
Zhao, X. et al. Dual effects of isoflurane on proliferation, differentiation, and survival in human neuroprogenitor cells. Anesthesiology 118, 537–549, https://doi.org/10.1097/ALN.0b013e3182833fae (2013).
Qiao, H. et al. Propofol Affects Neurodegeneration and Neurogenesis by Regulation of Autophagy via Effects on Intracellular Calcium Homeostasis. Anesthesiology: The Journal of the American Society of Anesthesiologists (2017).
Cattano, D., Young, C., Straiko, M. M. & Olney, J. W. Subanesthetic doses of propofol induce neuroapoptosis in the infant mouse brain. Anesth. Analg. 106, 1712–1714 (2008).
Creeley, C. et al. Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Br. J. Anaesth. 110(Suppl 1), i29–38, https://doi.org/10.1093/bja/aet173 (2013).
Zou, X. et al. Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey. Neurotoxicol. Teratol. 33, 592–597 (2011).
Wang, C., Nguyen, H. N., Maguire, J. L. & Perry, D. C. Role of intracellular calcium stores in cell death from oxygen-glucose deprivation in a neuronal cell line. J Cereb.Blood Flow Metab 22, 206–214 (2002).
Yang, H. et al. A new method to effectively and rapidly generate neurons from SH-SY5Y cells. Neurosci Lett 610, 43–47, https://doi.org/10.1016/j.neulet.2015.10.047 (2016).
Cree, I. A. & Andreotti, P. E. Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines. Toxicol. In Vitro 11, 553–556 (1997).
Chen, Z. et al. The roles of mitochondria in radiation-induced autophagic cell death in cervical cancer cells. Tumour Biol., https://doi.org/10.1007/s13277-015-4190-8 (2015).
Acknowledgements
We thank Dr. Kevin Foskett, Department of Physiology, University of Pennsylvania, USA for providing us with the valuable discussion. We appreciate valuable input from Dr. Charleen T. Chu from the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA, Dr. Ravi K Amaravadi, Department of Medicine, Dr. Ted Abel, Department of Biology, and Drs. Roderic Eckenhoff, Maryellen Eckenhoff, Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, USA. Supported by grants to HW from the National Institutes of Health (grant number: K08-GM073224, R01GM084979, 3R01GM084979-02S1, 2R01GM084979-06A1), the March of Dimes Birth Defects Foundation (grant number:#12-FY08-167), and the bridging fund from the Department of Anesthesiology, Perelman School of Medicine, University of Pennsylvania.
Author information
Authors and Affiliations
Contributions
G.R., Y.Z., G.L., B.Y. carried out experiments in various tissue cultures. H.W. conceived and designed the study, supervised all of the experiments and wrote the manuscript. M.Y. and A.K. constructed the final figures and helped write the manuscript. All authors discussed the results of the study, commented on the manuscript’s construction.
Corresponding author
Ethics declarations
Competing Interests
Dr. Huafeng Wei is an advisory board member of Eagle Pharmaceutical Company, New Jersey, USA. Other authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ren, G., Zhou, Y., Liang, G. et al. General Anesthetics Regulate Autophagy via Modulating the Inositol 1,4,5-Trisphosphate Receptor: Implications for Dual Effects of Cytoprotection and Cytotoxicity. Sci Rep 7, 12378 (2017). https://doi.org/10.1038/s41598-017-11607-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-11607-0
This article is cited by
-
Sevoflurane modulates breast cancer cell survival via modulation of intracellular calcium homeostasis
BMC Anesthesiology (2020)
-
Propofol affects mouse embryonic fibroblast survival and proliferation in vitro via ATG5- and calcium-dependent regulation of autophagy
Acta Pharmacologica Sinica (2020)
-
Lasting effects of general anesthetics on the brain in the young and elderly: “mixed picture” of neurotoxicity, neuroprotection and cognitive impairment
Journal of Anesthesia (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
